
LAMEES HEGAZY
@lameeshegazy
ID: 874398132062310400
12-06-2017 22:48:55
91 Tweet
86 Followers
255 Following


Thank you Amynah Amynah Pradhan! That was fun.

Another day another party! Thank you University of Health Sciences and Pharmacy in STL for hosting this wonderful Holiday Event! Wishing you all a Happy Holidays!



We had a great pleasure hosting Prof. Leahy today at our CCP seminar. Thank you Dr. Leahy for such wonderful talk. @ClinicPharmSTL University of Health Sciences and Pharmacy in STL @WUSTL_AnesRsrch





Breakthrough research from LAMEES HEGAZY, which was recently published in Nature Communications, offers new insights into the future development of new therapeutics for metabolic disorders and other diseases. Read more: bit.ly/3zRkQJq




I am honored to be invited as a speaker in the Schrödinger Global Educator's Week, a prominent event organized by the leading scientific company in the development of cutting-edge drug discovery software. I warmly invite you to join us University of Health Sciences and Pharmacy in STL @ClinicPharmSTL @WUSTL_AnesRsrch






Join us for the @ClinicPharmSTL Research Seminar feat. Dr. Abou-Gharbia from Temple University School of Pharmacy! 📆 Thurs, Nov. 9 ⏰ 1p 🔬 "Phenotypic & Target-Based Drug Discovery Approaches for the Discovery of Innovative Therapeutics" 📍 UHSP Academic & Research Bldg Rm 222 anesthesiology.wustl.edu/events/event/c…



A fantastic collaborative work with Che lab Tao & Gruber lab The Gruber Lab “Design and structural validation of peptide–drug conjugate ligands of the kappa-opioid receptor” University of Health Sciences and Pharmacy in STL @WUSTL_AnesRsrch @ClinicPharmSTL

How does SR8278, the only reported antagonist of REV-ERBα, bind? GaMD predicted binding mechanism of SR8278. SBVS in GaMD predicted binding site lead to discovery of novel first-in-class REV-ERBα antagonists (coming soon) University of Health Sciences and Pharmacy in STL @ClinicPharmSTL nature.com/articles/s4159…